Strain Information | |
---|---|
Image | |
BRC No. | RBRC06030 |
Type | Targeted Mutation |
Species | Mus musculus |
Strain name | B6;129S2-Kpna1<tm1.1Yyo> |
Former Common name | Impa5flox |
H-2 Haplotype | |
ES Cell line | D3 [129S2/SvPas] |
Background strain | |
Appearance | |
Strain development | Developed by Tetsuji Moriyama and Yoshihiro Yoneda, Graduate School of Frontier Biosciences, Osaka University in 2006. A neo cassette was removed by crossing with CAG-FLP mice (B6 background). |
Strain description | Kpna1 (IPOA5, Impoirtin alpha 5) gene floxed mice. Exons 2 and 3 were flanked by loxP sites. |
Colony maintenance | Homozygote x Homozygote [or Crossing to C57BL/6JJcl] |
References | Targeted disruption of one of the importin alpha family members leads to female functional incompetence in delivery. Moriyama T, Nagai M, Oka M, Ikawa M, Okabe M, Yoneda Y FEBS J., 278, 1561-1572 (2011). 21371262 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Frt | yeast FRT (flippase recombination target) site | 16 | Frt | ||||
Kpna1 | karyopherin subunit alpha 1 | 16 | Kpna1 | targeted mutation 1.1, Yoshihiro Yoneda | |||
loxP | phage P1 loxP | 16 | loxP | ||||
loxP | phage P1 loxP | 16 | loxP |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | Bacteriophage P1 locus of X-over P1 (loxP), Saccharomyces cerevisiae Flippase recognition target (FRT), Mouse Kpna1 genomic DNA |
Research application | Cell Biology Research Cre/loxP system FLP/frt system Immunology and Inflammation Research |
Specific Term and Conditions | Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEPOSITOR using the Approval Form. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. FEBS J., 278, 1561-1572 (2011).In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, the RECIPIENT must contact the DEPOSITOR and notify him the research content. If the DEPOSITOR judges that the research should be a collaborative work, then the RECIPIENT must include the DEPOSITOR/DEVELOPER as co-authors. |
Depositor | Masahiro Oka (National Institutes of Biomedical Innovation, Health and Nutrition) |
Strain Status | Frozen embryos |
Strain Availability | Recovery and QC required prior to distribution |
Additional Info. | Necessary documents for ordering: |
BRC mice in Publications |
---|
No Data |